Danaher Corporation (NYSE:DHR) Shares Bought by Wealthfront Advisers LLC

Wealthfront Advisers LLC lifted its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 8.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 58,503 shares of the conglomerate's stock after purchasing an additional 4,645 shares during the period. Wealthfront Advisers LLC's holdings in Danaher were worth $11,993,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also made changes to their positions in the company. FAS Wealth Partners Inc. lifted its holdings in Danaher by 20.6% in the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock valued at $2,203,000 after purchasing an additional 1,639 shares in the last quarter. Horizon Financial Services LLC lifted its stake in shares of Danaher by 20,400.0% in the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after buying an additional 8,160 shares in the last quarter. Asahi Life Asset Management CO. LTD. purchased a new stake in Danaher during the 1st quarter valued at about $539,000. Vision Capital Management Inc. acquired a new stake in Danaher in the 1st quarter valued at about $461,000. Finally, Compass Wealth Management LLC lifted its stake in Danaher by 17.4% in the 1st quarter. Compass Wealth Management LLC now owns 39,764 shares of the conglomerate's stock worth $8,152,000 after purchasing an additional 5,891 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Insider Activity

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president owned 15,179 shares in the company, valued at approximately $3,005,442. This represents a 51.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman owned 3,105,808 shares of the company's stock, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

DHR has been the subject of several recent research reports. HSBC cut their price target on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Scotiabank raised shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target on the stock in a research report on Friday, July 11th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Bank of America reduced their price objective on shares of Danaher from $265.00 to $230.00 in a report on Monday, April 14th. Finally, Guggenheim reaffirmed a "buy" rating and set a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. Three research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $248.43.

Danaher Stock Performance

DHR traded up $1.33 during trading on Thursday, hitting $194.63. 1,931,260 shares of the stock were exchanged, compared to its average volume of 3,514,154. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $281.70. The stock has a fifty day moving average price of $196.12 and a two-hundred day moving average price of $205.72. The firm has a market capitalization of $139.29 billion, a P/E ratio of 37.75, a PEG ratio of 2.71 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 15.81% and a return on equity of 10.80%. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. As a group, sell-side analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.66%. Danaher's payout ratio is 24.85%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.